No decision is without risk

Journal of Clinical Psychiatry

Volumn 70, Issue 9, 2009, Pages 1319-

  Suri, Rita ^a   Altshuler, Lori L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN;

ADVERSE OUTCOME; BEHAVIOR CHANGE; DISEASE SEVERITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LOW BIRTH WEIGHT; MAJOR DEPRESSION; PATIENT DECISION MAKING; PATIENT INFORMATION; PREGNANCY; PREGNANT WOMAN; PREMATURITY; PRENATAL CARE; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PSYCHOTHERAPY; SHORT SURVEY; SIGNAL TRANSDUCTION; SLEEP DISORDER; ARTICLE; ATTITUDE TO HEALTH; DECISION MAKING; FEMALE; METHODOLOGY; PREGNANCY COMPLICATION; PUERPERAL DEPRESSION; RECURRENT DISEASE; RISK FACTOR;

ANTIDEPRESSIVE AGENTS; ATTITUDE TO HEALTH; DECISION MAKING; DEPRESSION, POSTPARTUM; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PSYCHOTHERAPY; RECURRENCE; RISK FACTORS;

EID: 70350458716     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.09com05529     Document Type: Short Survey

References (20)

1. Evans J, Heron J, Francomb H, et al. Cohort study of depressed mood during pregnancy and after childbirth. BMJ. 2001;323(7307):257-260. PubMed doi:10.1136/bmj.323.7307.257 (Pubitemid 32729111)
2. Marcus SM, Flynn HA, Blow FC, et al. Depressive symptoms among pregnant women screened in obstetrics settings. J Womens Health (Larchmt). 2003;12(4):373-380. PubMed doi:10.1089/154099903765448880
3. De Tychey C, Spitz E, Briancon S, et al. Pre- and postnatal depression and coping: a comparative approach. J Affect Disord. 2005;85(3):323-326. PubMed doi:10.1016/j.jad.2004.11.004 (Pubitemid 40386516)
4. O'Hara MW, Schlechte JA, Lewis DA, et al. Controlled prospective study of postpartum mood disorders: psychological, environmental, and hormonal variables. J Abnorm Psychol. 1991;100(1):63-73. PubMed doi:10.1037/0021-843X. 100.1.63
5. Cohen LS, Altshuler LL, Harlow BL, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA. 2006;295(5):499-507. PubMed doi:10.1001/jama.295.5.499
6. Einarson A, Choi J, Einarson TR, et al. Incidence of major malformations in infants following antidepressant exposure in pregnancy: results of a large prospective cohort study. Can J Psychiatry. 2009;54(4):242-246. PubMed
7. Chambers CD, Johnson KA, Dick LM, et al. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med. 1996;335(14):1010-1015. PubMed doi:10.1056/NEJM199610033351402
8. Ericson A, Kallen B, Wiholm B. Delivery outcome after the use of antidepressants in early pregnancy. Eur J Clin Pharmacol. 1999;55(7):503-508. PubMed doi:10.1007/s002280050664 (Pubitemid 29446550)
9. Oberlander TF, Warburton W, Misri S, et al. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry. 2006;63(8):898-906. PubMed doi:10.1001/archpsyc.63.8.898 (Pubitemid 44188483)
10. Wisner KL, Sit DKY, Hanusa BH, et al. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. Am J Psychiatry. 2009;166(5):557-566. PubMed doi:10.1176/appi.ajp.2008.08081170
11. Suri R, Altshuler L, Hellemann G, et al. Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. Am J Psychiatry. 2007;164(8):1206-1213. PubMed doi:10.1176/appi.ajp.2007. 06071172 (Pubitemid 47292409)
12. Moses-Kolko EL, Bogen D, Perel J, et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA. 2005;293(19):2372-2383. PubMed doi:10.1001/jama.293.19.2372 (Pubitemid 40676760)
13. Louik C, Lin AE, Werler MM, et al. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med. 2007;356(26):2675-2683. PubMed doi:10.1056/NEJMoa067407 (Pubitemid 47001035)
14. Alwan S, Reefhuis J, Rasmussen SA, et al. National birth defects prevention study: use of selective serotoninreuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med. 2007;356(26):2684-2692. PubMed doi:10.1056/NEJMoa066584
15. Chambers CD, Hernandex-Diaz S, Ban Marter LJ, et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med. 2006;354(6):579-587. PubMed doi:10.1056/NEJMoa052744
16. Steer RA, Scholl TO, Hediger ML, et al. Self-reported depression and negative pregnancy outcomes. J Clin Epidemiol. 1992;45(10):1093-1099. PubMed doi:10.1016/0895-4356(92)90149-H
17. Field T, Diego M, Hernandez-Reif M, et al. Sleep disturbances in depressed pregnant women and their newborns. Infant Behav Dev. 2007;30(1):127-133. PubMed doi:10.1016/j.infbeh.2006.08.002 (Pubitemid 46202012)
18. Deave T, Heron J, Evans J, et al. The impact of maternal depression in pregnancy on early child development. BJOG. 2008;115(8):1043-1051. PubMed doi:10.1111/j.1471-0528.2008.01752.x (Pubitemid 351841766)
19. Luoma I, Tamminen T, Kaukonen P, et al. Longitudinal study of maternal depressive symptoms and child well-being. J Am Acad Child Adolesc Psychiatry. 2001;40(12):1367-1374. PubMed doi:10.1097/00004583-200112000-00006 (Pubitemid 34250955)
20. Suri R, Altshuler LA, Mintz J. Depression and the decision to abort. Am J Psychiatry. 2004;161(8):1502. PubMed doi:10.1176/appi.ajp.161.8.1502